TP53 and hepatocellular carcinoma: Given that miR-483-3p was proven to have an oncogenic role in HCC5 and to inhibit the pro-apoptotic pathway induced by miR-145-5p and TP53,4 we hypothesize that 2-DG could reduce miR-483-3p expression and increase the efficacy of chemotherapeutic treatments in HCC cells.